MicroRNome analysis unravels the molecular basis of SARS infection in bronchoalveolar stem cells

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Mallick, Bibekanand ^a   Ghosh, Zhumur ^b   Chakrabarti, Jayprokas ^a  

^a DEPARTMENT OF MATERIALS SCIENCE   (India)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; MICRORNA; OCTAMER TRANSCRIPTION FACTOR 4; POU5F1 PROTEIN, MOUSE;

ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CLINICAL FEATURE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENOME ANALYSIS; HUMAN; HUMAN CELL; LUNG ALVEOLUS CELL; LUNG FIBROSIS; LUNG INSUFFICIENCY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN INTERACTION; SEVERE ACUTE RESPIRATORY SYNDROME; STEM CELL; TISSUE REPAIR; UPREGULATION; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS REPLICATION; VIRUS TRANSMISSION; ANIMAL; BRONCHUS; CHEMISTRY; CYTOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; LUNG; LUNG ALVEOLUS; METABOLISM; SARS CORONAVIRUS; VIRUS NUCLEOCAPSID;

CORONAVIRUS; SARS CORONAVIRUS;

ANIMALS; BRONCHI; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENOME, VIRAL; HUMANS; LUNG; MICE; MICRORNAS; NUCLEOCAPSID; OCTAMER TRANSCRIPTION FACTOR-3; PULMONARY ALVEOLI; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; STEM CELLS;

EID: 70649096183     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007837     Document Type: Article

References (68)

1. Donnelly CA, Ghani AC, Leung GM, Hedley AJ, Fraser C, et al. (2003) Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. Lancet 361: 1761-1766.
2. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, et al. (2003) A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 348(20): 1953-1966.
3. Poutanen SM, Low DE, Henry B, Finkelstein S, Rose D, et al. (2003) Identification of severe acute respiratory syndrome in Canada. N Engl J Med 348(20): 1995-2005.
4. Marra MA, Jones SJ, Astell CR, Holt RA, Brooks-Wilson A, et al. (2003) The genome sequence of the SARS-associated coronavirus. Science 300: 1399-1404.
5. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, et al. (2003) Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 300: 1394-1399.
6. Gu J, Gong E, Zhang B, Zheng J, Gao Z, et al. (2005) Multiple organ infection and the pathogenesis of SARS. J Exp Med 202(3): 415-424.
7. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, et al. (2003) Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 362(9380): 263-270.
8. Ling TY, Kuo MD, Li CL, Yu AL, Huang YH, et al. (2006) Identification of pulmonary Oct-4+ stem/progenitor cells and demonstration of their susceptibility to SARS coronavirus (SARS-CoV) infection in vitro. Proc Natl Acad Sci USA 103(25): 9530-9535.
9. Hong KU, Reynolds SD, Watkins S, Fuchs E, Stripp BR (2004) Basal cells are a multipotent progenitor capable of renewing the bronchial epithelium. Am J Pathol 164(2): 577-588.
10. Evans MJ, Cabral-Anderson LJ, Freeman G (1978) Role of the Clara cell in renewal of the bronchiolar epithelium. Lab Invest 38: 648-653.
11. Fehrenbach H (2001) Alveolar epithelial type II cell: defender of the alveolus revisited. Respir Res 2: 33-46.
12. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, et al. (2005) Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 121(6): 823-835.
13. Lu M, Zhang Q, Deng M, Miao J, Guo Y, et al. (2008) An analysis of human microRNA and disease associations. PLoS ONE 3(10): e3420. doi:10.1371/ journal.pone.0003420.
14. Ghosh Z, Mallick B, Chakrabarti J (2009) Cellular versus viral microRNAs in host-virus interaction. Nucleic Acids Res 37(4): 1035-1048.
15. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116(2): 281-297.
16. Ghosh Z, Chakrabarti J, Mallick B (2007) miRNomics-The bioinformatics of microRNA genes. Biochem Biophys Res Commun 37(4): 1035-1048.
17. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, et al. (2003) Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426(6965): 450-454.
18. Li X, Molina-Molina M, Abdul-Hafez A, Uhal V, Xaubet A, et al. (2008) Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis. Am J Physiol Lung Cell Mol Physiol 295(1): L178-185.
19. Zhao X, Nicholls JM, Chen Y-G (2008) Severe Acute Respiratory Syndrome-associated coronavirus nucleocapsid protein interacts with Smad3 and modulates transforming growth factor-{beta} signaling. J Biol Chem 283: 3272-3280.
20. Yu ITS, Li Y, Wong TW, Tam W, Chan AT, et al. (2004) Evidence of airborne transmission of the Severe Acute Respiratory Syndrome virus. New Eng J Med 350: 1731-1739.
21. Jia HP, Look DC, Shi L, Hickey M, Pewe L, et al. (2005) ACE2 receptor expression and severe acute respiratory syndrome coronavirus infection depend on differentiation of human airway epithelia. J Virol 79(23): 14614-14621.
22. Campbell PA, Perez-Iratxeta C, Andrade-Navarro MA, Rudnicki MA (2007) Oct4 targets regulatory nodes to modulate stem cell function. PLoS ONE 2(6): e553. doi:10.1371/journal.pone.0000553.
23. Chen Y, Chan VS, Zheng B, Chan KY, Xu X, et al. (2007) A novel subset of putative stem/progenitor CD34+Oct-4+ cells is the major target for SARS coronavirus in human lung. J Exp Med 204(11): 2529-2536.
24. Yilla M, Harcourt BH, Hickman CJ, McGrew M, Tamin A, Goldsmith CS, Bellini WJ, Anderson LJ (2005) SARS-coronavirus replication in human peripheral monocytes/macrophages. Virus Research 107: 93-101.
25. Shcherbata HR, Hatfield S, Ward EJ, Reynolds S, Fischer KA, et al. (2006) The MicroRNA pathway plays a regulatory role in stem cell division. Cell Cycle 5: 172-175.
26. Zhang B, Pan X, Anderson TA (2006) MicroRNA: A new player in stem cells. J Cell Physiol 209: 266-269.
27. McQualter JL, Brouard N, Williams B, Baird BN, Sims-Lucas S, et al. (2009) Endogenous fibroblastic progenitor cells in the adult mouse lung are highly enriched in the sca-1 positive cell fraction. Stem Cells 27(3): 623-633.
28. Martin U (2008) Methods for studying stem cells: Adult stem cells for lung repair. Methods 45(2): 121-132.
29. Eramo A, Lotti F, Sette G, Pilozzi E, Biffoni M, et al. (2008) Identification and expansion of the tumorigenic lung cancer stem cell population. Cell Death Differ 15: 504-514.
30. Kim CF (2007) Paving the road for lung stem cell biology: bronchioalveolar stem cells and other putative distal lung stem cells. Am J Physiol Lung Cell Mol Physiol 293: 1092-1098.
31. Nielsen S, King LS, Christensen BM, Agre P (1997) Aquaporins in complex tissues. II. Subcellular distribution in respiratory and glandular tissues of rat. Am J Physiol 273: C1549-1561.
32. Oudit GY, Imai Y, Kuba K, Scholey JW, Penninger JM (2009) The role of ACE2 in pulmonary diseases-relevance for the nephrologist. Nephrol Dial Transplant 24(5): 1362-1365.
33. Glass WG, Subbarao K, Murphy B, Murphy PM (2004) Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice. J Immunol 173(6): 4030-4039.
34. Tokuda A, Itakura M, Onai N, Kimura H, Kuriyama T, et al. (2000) Pivotal role of CCR1-positive Llukocytes in bleomycin- induced lung fibrosis in mice. J Immunol 164: 2745-2751.
35. Gallagher TM, Buchmeier MJ (2001) Coronavirus spike proteins in viral entry and pathogenesis. Virology 279: 371-374.
36. Wilson L, Mckinlay C, Gage P, Ewart G (2004) SARS coronavirus E protein forms cation-selective ion channels. Virology 330(1): 322-331.
37. Chana C-M, Maa C-W, Chan WY, Chan HYE (2007) The SARS-Coronavirus Membrane protein induces apoptosis through modulating the Akt survival pathway. Archiv Biochem Biophys 459(2): 197-207.
38. Milan S, Lal SK (2008) The SARS-CoV nucleocapsid protein: a protein with multifarious activities. Infection, genetics and evolution 8(4): 397-405.
39. Yan X, Hao Q, Mu Y, Timani KA, Ye L, et al. (2006) Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/ enhancer binding protein. Int J Biochem Cell Biol 38(8): 1417-1428.
40. Snijder EJ, Bredenbeek PJ, Dobbe JC, Thiel V, Ziebuhr J, et al. (2003) Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage. J Mol Biol 331(5): 991-1004.
41. Prentice E, McAuliffe J, Lu X, Subbarao K, Denison MR (2004) Identification and characterization of severe acute respiratory syndrome coronavirus replicase proteins. J Virol 78(18): 9977-9986.
42. Watanabe Y, Kishi A, Yachie N, Kanai A, Tomita M (2007) Computational analysis of microRNA-mediated antiviral defense in humans. FEBS Lett 581(24): 4603-4610.
43. Ye R, Montalto-Morrison C, Masters PS (2004) Genetic analysis of determinants for spike glycoprotein assembly into murine coronavirus virions: distinct roles for charge-rich and cysteine-rich regions of the endodomain. J Virol 78(18): 9904-9917.
44. Nicholls JM, Poon LLM, Lee KC, Ng WF, Lai SK, et al. (2003) Lung pathology of fatal severe acute respiratory syndrome. Lancet 361: 1773-1778.
45. Xiao X, Chakraborti S, Dimitrov AS, Gramatikoff K, Dimitrov DS (2003) The SARS-CoV S glycoprotein: Expression and functional characterization. Biochem Biophys Res Commun 312: 1159-1164.
46. Kuba K, Imai Y, Rao S, Gao H, Guo F, et al. (2005) A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury. Nat Med 11(8): 875-879.
47. Imai Y, Kuba K, Penninger JM (2008) The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol 93(5): 543-548.
48. Jin DY, Zheng BJ (2009) Roles of spike protein in the pathogenesis of SARS coronavirus. Hong Kong Med J 15(Suppl 2): S37-40.
49. Yan X, Hao Q, Mu Y, Timani KA, Ye L, et al. (2006) Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/ enhancer binding protein. Int J Biochem Cell Biol 38(8): 1417-1428.
50. Bonville CA, Easton AJ, Rosenberg HF, Domachowske JB (2003) Altered pathogenesis of severe pneumovirus infection in response to combined anti-viral and specific immunomodulatory agents. J Virol 77: 1237-1244.
51. Lee B-N, Ordonez N, Popek EJ, Lu J-G, Helfgott A, et al. (1997) Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells. J Virol 1: 3628-3635.
52. Chang J, Renne R, Dittmer D, Ganem D (2000) Inflammatory cytokines and the reactivation of Kaposi's sarcoma-associated herpesvirus lytic replication. Virol 266(1): 17-25.
53. Asirvatham AJ, Gregorie CJ, Hu Z, Magner WJ, Tomasi TB (2008) MicroRNA targets in immune genes and the Dicer/argonaute and ARE machinery components. Mol Immunol 45: 1995-2006.
54. Baltimore D, Boldin MP, O'Connell RM, Rao DS, Taganov KD (2008) MicroRNAs: new regulators of immune cell development and function. Nat Immunol 9: 839-845.
55. Fazi F, Rosa A, Fatica A, Gelmetti V, De Marchis ML, et al. (2005) A minicircuitry comprised of microRNA-223 and transcription factors NFI-A and C/EBPalpha regulates human granulopoiesis. Cell 123: 819-831.
56. Law HK, Cheung CY, Sia SF, Chan YO, Peiris JM, et al. (2009) Toll-like receptors, chemokine receptors and death receptor ligands responses in SARS coronavirus infected human monocyte derived dendritic cells. BMC Immunol 10(1): 35.
57. Cinati J, Morgenstern B, Bauer G, Chandra P, Doerr HW, et al. (2003) Treatment of SARS with human interferons. Lancet 362: 293-294.
58. Wu CJ, Jan JT, Chen CM, Hsieh HP, Hwang DR, et al. (2004) Inhibition of Severe Acute Respiratory Syndrome Coronavirus Replication by Niclosamide. AAC 48(7): 2693-2696.
59. Wu CJ, Huang HW, Liu CY, Hong CF, Chan YL (2005) Inhibition of SARSCoV replication by siRNA. Antiviral Research 65: 45-48.
60. Li BJ, Tang Q, Cheng Du, Qin C, Xie FY, et al. (2005) Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque. Nat Med 11(9): 944-951.
61. Qian S, Ding J, Xie R, An JH, Ao XJ, et al. (2008) MicroRNA expression profile of bronchioalveolar stem cells from mouse lung. Biochem Biophys Res Commun 377: 668-673.
62. Williams AE, Moschos SA, Perry MM, Barnes PJ, Lindsay MA (2007) Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev Dyn 236(2): 572-580.
63. Mignone F, Grillo G, Licciulli F, Iacono M, Liuni S, et al. (2005) UTRdb and UTRsite: a collection of sequences and regulatory motifs of the untranslated regions of eukaryotic mRNAs. Nucleic Acids Res 33: D141-146.
64. Rehmsmeier M, Steffen P, Höchsmann M, Giegerich R (2004) Fast and effective prediction of microRNA/target duplexes. RNA 10: 1507-1517.
65. Grimson A, Farh KK, Johnston WK, Garrett-Engele P, Lim LP, et al. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol Cell 27: 91-105.
66. Friedman RC, Farh KK, Burge CB, Bartel DP (2009) Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19: 92-105.
67. Bartel DP (2009) MicroRNAs: Target recognition and regulatory functions. Cell 136: 215-233.
68. Bolstad BM, Irizarry RA, Astrand M, Speed TP (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.